BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 22, 2000
View Archived Issues
BioPulse and Brigham Young partner on major cancer diagnostic breakthrough
Read More
PathoGenome database utilized for antiinfective drug discovery
Read More
Eisai responsible for Japanese development, marketing of botulinum toxin type B
Read More
Conformationally constrained butyrophenones as potential antipsychotic agents
Read More
Cellegy begins expanded phase I/II trial with Tostrelle; new collaboration on FSD announced
Read More
Alza licenses dapoxetine from PPD GenuPro
Read More
Ranolazine enters phase II for CHF
Read More
Apthera for canker sores approved in Canada
Read More
Phenserine enters phase II trial for Alzheimer's disease
Read More
Anti-IL-9 antibody collaboration terminated by Genentech
Read More
York Medical changes name, reports pipeline progress
Read More
VX-148 enters clinical development
Read More
Potent, selective proteasome compounds derived from belactosin
Read More
Mitsubishi-Tokyo stops development of antidepressant MCI-225
Read More
Development of MKC-542 under consideration at Mitsubishi-Tokyo
Read More
TKT reacquires rights to second Gene-Activated Protein from Aventis
Read More
Preclinical trials with decitabine suggest potential in myelodysplastic syndrome, multiple myeloma
Read More
Schering-Plough to market pranlukast in Latin America
Read More
Potential of tegaserod in GERD therapy indicated by recent clinical study findings
Read More
Spanish researchers claim novel antiviral agents
Read More
Taisho presents new compounds with potential in the treatment of renal and cardiovascular conditions
Read More
Pyrazole derivatives from Yamanouchi inhibit CRACC and IL-2 production
Read More
Recent patent covers new GnRH antagonists prepared by Merck scientists
Read More
Prostaglandin analogues for glaucoma, ocular hypertension described in December patent
Read More
New oncolytic drugs from Schering-Plough act by inhibiting protein farnesyltransferase
Read More
Dual inhibitors of ACE/NEP in development at Toa Eiyo
Read More